Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Usefulness of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide as biomarkers for heart failure in young children with single ventricle congenital heart disease.

Lowenthal A, Camacho BV, Lowenthal S, Natal-Hernandez L, Liszewski W, Hills NK, Fineman JR, Bernstein HS.

Am J Cardiol. 2012 Mar 15;109(6):866-72. doi: 10.1016/j.amjcard.2011.10.049.

2.

The potential and limitations of plasma BNP measurement in the diagnosis, prognosis, and management of children with heart failure due to congenital cardiac disease: an update.

Cantinotti M, Law Y, Vittorini S, Crocetti M, Marco M, Murzi B, Clerico A.

Heart Fail Rev. 2014 Nov;19(6):727-42. doi: 10.1007/s10741-014-9422-2. Review.

PMID:
24473828
3.

The potential role of natriuretic peptides and other biomarkers in heart failure diagnosis, prognosis and management.

Ibrahim N, Januzzi JL.

Expert Rev Cardiovasc Ther. 2015;13(9):1017-30. doi: 10.1586/14779072.2015.1071664. Review.

PMID:
26198476
4.

Diagnostic Accuracy of Natriuretic Peptides for Heart Failure in Patients with Pleural Effusion: A Systematic Review and Updated Meta-Analysis.

Han ZJ, Wu XD, Cheng JJ, Zhao SD, Gao MZ, Huang HY, Gu B, Ma P, Chen Y, Wang JH, Yang CJ, Yan ZH.

PLoS One. 2015 Aug 5;10(8):e0134376. doi: 10.1371/journal.pone.0134376. Review.

5.

Changes of natriuretic peptides predict hospital admissions in patients with chronic heart failure: a meta-analysis.

Savarese G, Musella F, D'Amore C, Vassallo E, Losco T, Gambardella F, Cecere M, Petraglia L, Pagano G, Fimiani L, Rengo G, Leosco D, Trimarco B, Perrone-Filardi P.

JACC Heart Fail. 2014 Apr;2(2):148-58. doi: 10.1016/j.jchf.2013.11.007. Review.

PMID:
24720923
6.

B-type natriuretic peptide as a parameter for pulmonary hypertension in children. A systematic review.

Ten Kate CA, Tibboel D, Kraemer US.

Eur J Pediatr. 2015 Oct;174(10):1267-75. doi: 10.1007/s00431-015-2619-0. Review.

PMID:
26298682
7.

Obesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failure.

Madamanchi C, Alhosaini H, Sumida A, Runge MS.

Int J Cardiol. 2014 Oct 20;176(3):611-7. doi: 10.1016/j.ijcard.2014.08.007. Review.

8.

Testing for BNP and NT-proBNP in the diagnosis and prognosis of heart failure.

Balion C, Santaguida PL, Hill S, Worster A, McQueen M, Oremus M, McKelvie R, Booker L, Fagbemi J, Reichert S, Raina P.

Evid Rep Technol Assess (Full Rep). 2006 Sep;(142):1-147. Review.

9.

Clinical implications of B-type natriuretic peptide and N-terminal pro--B-type natriuretic peptide in the care of the vascular surgery patient.

Wayne Causey M, Singh N.

Semin Vasc Surg. 2014 Dec;27(3-4):143-7. doi: 10.1053/j.semvascsurg.2015.01.004. Review.

PMID:
26073822
10.

BNP in children with congenital cardiac disease: is there now sufficient evidence for its routine use?

Cantinotti M, Walters HL, Crocetti M, Marotta M, Murzi B, Clerico A.

Cardiol Young. 2015 Mar;25(3):424-37. doi: 10.1017/S1047951114002133. Review.

PMID:
25601330
11.

Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms.

Januzzi JL Jr, Chen-Tournoux AA, Moe G.

Am J Cardiol. 2008 Feb 4;101(3A):29-38. doi: 10.1016/j.amjcard.2007.11.017. Review.

PMID:
18243855
12.

The biologic variability of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in stable heart failure patients.

O'Hanlon R, O'Shea P, Ledwidge M, O'Loughlin C, Lange S, Conlon C, Phelan D, Cunningham S, McDonald K.

J Card Fail. 2007 Feb;13(1):50-5. Review. Erratum in: J Card Fail. 2007 Mar;13(2):163.

PMID:
17339003
13.

Amino-Terminal Pro-B-Type Natriuretic Peptide for Diagnosis and Prognosis in Patients With Renal Dysfunction: A Systematic Review and Meta-Analysis.

Schaub JA, Coca SG, Moledina DG, Gentry M, Testani JM, Parikh CR.

JACC Heart Fail. 2015 Dec;3(12):977-89. doi: 10.1016/j.jchf.2015.07.014. Review.

14.
15.

B-type natriuretic peptides and mortality after stroke: a systematic review and meta-analysis.

García-Berrocoso T, Giralt D, Bustamante A, Etgen T, Jensen JK, Sharma JC, Shibazaki K, Saritas A, Chen X, Whiteley WN, Montaner J.

Neurology. 2013 Dec 3;81(23):1976-85. doi: 10.1212/01.wnl.0000436937.32410.32. Review.

16.

B-type natriuretic peptides help in cardioembolic stroke diagnosis: pooled data meta-analysis.

Llombart V, Antolin-Fontes A, Bustamante A, Giralt D, Rost NS, Furie K, Shibazaki K, Biteker M, Castillo J, Rodríguez-Yáñez M, Fonseca AC, Watanabe T, Purroy F, Zhixin W, Etgen T, Hosomi N, Jafarian Kerman SR, Sharma JC, Knauer C, Santamarina E, Giannakoulas G, García-Berrocoso T, Montaner J.

Stroke. 2015 May;46(5):1187-95. doi: 10.1161/STROKEAHA.114.008311. Review.

17.
18.

BNP molecular forms and processing by the cardiac serine protease corin.

Ichiki T, Huntley BK, Burnett JC Jr.

Adv Clin Chem. 2013;61:1-31. Review.

19.

Molecular forms of natriuretic peptides in heart failure and their implications.

Xu-Cai YO, Wu Q.

Heart. 2010 Mar;96(6):419-24. doi: 10.1136/hrt.2008.164145. Review.

20.

Current and novel biomarkers in heart failure: bench to bedside.

Ghashghaei R, Arbit B, Maisel AS.

Curr Opin Cardiol. 2016 Mar;31(2):191-5. doi: 10.1097/HCO.0000000000000254. Review.

PMID:
26814650
Items per page

Supplemental Content

Support Center